Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Aug 8:2020:5892047.
doi: 10.1155/2020/5892047. eCollection 2020.

Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient

Sam K Touisserkani  1 , Azin Ayatollahi  2
Affiliations
Case Reports

Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient

Sam K Touisserkani et al. Case Rep Otolaryngol. .

Abstract

Coronavirus disease 2019 (COVID-19) is a highly infectious respiratory illness caused by SARS-CoV-2. Not much is yet known about this new viral disease. In our early encounter with the COVID-19, before the pandemic and during the early days of dealing with this novel viral disease in our country, we saw some cases of anosmia in patients infected by SARS-CoV-2. In many cases, this chemosensitive dysfunction persisted after the negativization of the nasopharyngeal swab. We report effective treatment of anosmia by oral corticosteroid therapy in a patient recovered from COVID-19.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Patchy ground-glass and peripheral infiltration in chest CT scan.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Shi H., Han X., Jiang N., et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. The Lancet Infectious Diseases. 2020;20(4):425–434. doi: 10.1016/S1473-3099(20)30086-4. - DOI - PMC - PubMed
    1. Cho S. H. Clinical diagnosis and treatment of olfactory dysfunction. Hanyang Medical Reviews. 2014;34(3):107–115. doi: 10.7599/hmr.2014.34.3.107. - DOI
    1. Suzuki M., Saito K., Min W.-P., et al. Identification of viruses in patients with postviral olfactory dysfunction. The Laryngoscope. 2007;117(2):272–277. doi: 10.1097/01.mlg.0000249922.37381.1e. - DOI - PMC - PubMed
    1. Sungnak W., Huang N., Huang N., et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nature Medicine. 2020;26(5):681–687. doi: 10.1038/s41591-020-0868-6. - DOI - PMC - PubMed
    1. Lechien J. R., Chiesa-Estomba C. M., De Siati D. R., et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. European Archives of Oto-Rhino-Laryngology. 2020;277(8):2251–2261. doi: 10.1007/s00405-020-05965-1. - DOI - PMC - PubMed

Publication types

LinkOut - more resources